Subscribe To

Price Alert Latest News Economic Calendar News

PROC / Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022. Read More

Demo Live Account See Partner Details

Content Topics

Procaps

Group

Report

Third

Quarter

Nine

Months

2022

November

Stock

PROC

Posted: Nov 8 2022, 15:36

Author Name: GlobeNewsWire

PROC News

By Zacks Investment Research
September 5, 2023

Procaps Group, S.A. (PROC) Q2 Earnings Surpass Estimates

Procaps Group, S.A. (PROC) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.06 per share.

By Business Wire
August 31, 2023

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesda

By GlobeNewsWire
May 1, 2023

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading

By Seeking Alpha
November 16, 2022

Procaps Group, S.A. (PROC) Q3 2022 Earnings Call Transcript

Procaps Group, S.A. (NASDAQ:PROC ) Q3 2022 Earnings Conference Call November 16, 2022 4:00 PM ET Company Participants Melissa Angelini - IR, Director

By GlobeNewsWire
November 8, 2022

Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcar

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.